<ul><li><keyword id="146847" type="General" weightage="20" keywordseo="mankind-pharma" source="Orion">Mankind Pharma</keyword> files for IPO which will comprise an offer for sale (OFS) of over 4 crore equity shares by the company's promoters and existing shareholders.</li><li>Some of its brands across categories include Manforce condoms <keyword id="3679921" type="General" weightage="20" keywordseo="Prega-News" source="Orion">Prega News</keyword> and Unwanted-72.</li><li>It also manufactures antacid powders, vitamin and mineral supplements and anti-acne preparations categories.</li><li>Its profitability has grown 37% in the last three financial years.</li></ul>Condom manufacturer Mankind Pharma has filed its draft red herring prospectus (DRHP) papers with market regulator SEBI to raise funds through initial public offering (IPO) route. The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the company's promoters and existing shareholders. Therefore, the company will not receive any proceeds from the offer and all the money will be received by the selling shareholders. The company manufactures a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its wide range of offerings include condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations categories. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Financials of some famous brands owned by company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Domestic sales </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">% market share </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Manforce (condom) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹451 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">30.2% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Prega News (pregnancy detection kit) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹152 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">80.1% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Unwanted-72 (emergency contraceptives) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹90 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">59.2% </td></tr></tbody></table> It has 23 manufacturing facilities across Himachal Pradesh, Sikkim, Rajasthan, Andhra Pradesh, Maharashtra and Uttarakhand. The company is also looking to acquire brands and diversify its therapeutic portfolio. “We aim to deepen our presence in our existing markets and facilitate our entry into new markets. We intend to strategically acquire brands and companies across key markets as well as explore in-licensing and codevelopment opportunities with other companies to diversify our therapeutic portfolio,” the company said in its DRHP. Its products are sold in 20 countries, including the US, Latin America, Southeast Asia, Africa, the Middle East and the Commonwealth of Independent States (CIS). Mankind Pharma’s profitability has grown 37% in the last three financial years. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Particulars </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Revenue from operations </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Profit </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY22 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹7,781 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,452 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY21 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹6,214 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,293 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY20 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹5,865 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹ 1,056 crore </td></tr></tbody></table> SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/vedanta-slips-9-after-it-clarifies-semiconductor-venture-to-be-undertaken-by-volcan-investments/articleshow/94243055.cms">Vedanta slips 9% after it clarifies semiconductor venture to be undertaken by Volcan Investments</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/india/cheetahs-are-coming-back-this-can-boost-the-health-of-indias-shrinking-grasslands/articleshow/94243760.cms">Cheetahs are coming back – this can boost the health of India’s shrinking grasslands</a>

Condom maker Mankind Pharma files papers for an IPO

Manforce Condoms aims to capture 50% market share by 2023

<ul><li><keyword id="2796952" type="PERSON" weightage="20" keywordseo="Manforce-Condoms">Manforce Condoms</keyword>’ latest campaign is a masterstroke. </li><li>The brand is urging people to use a condom, even if it is their competitors. </li></ul>Every year December 1 is observed as <keyword id="34644" type="PERSON" weightage="20" keywordseo="World-AIDS-Day">World AIDS Day</keyword> to raise awareness and knowledge about HIV and a call to move towards ending the HIV epidemic. It’s an opportunity for people worldwide to unite in the fight against HIV, to show support for people living with HIV, and to commemorate those who have died from an AIDS-related illness. Manforce Condoms has come up with a new campaign #StandTogether, urging people to protect India against HIV. As a leading brand in the industry, Manforce, through this campaign focuses on a larger responsibility of educating people to use condoms, no matter what brand you use. <div type="Youtube" id="wkX3xuHofE0" title="WorldAIDSDay" thumbUrl="https://i.ytimg.com/vi/wkX3xuHofE0/mqdefault.jpg"></div> The campaign highlights the importance of using condoms to fight against HIV and at same time communicates that the brand doesn’t matter. The most important is the health and safety of everyone and addresses the relevant issues related to safe sex with an appeal to enthusiastic lovers to have protected sex. In India, people are either shy, or are not aware enough about the use and importance of protection to stay away from AIDS. It is important to have conversations on sex education in schools to conversations at home. Society should never step back with the fact that condoms play a crucial role in the industry and understand the safety side of it instead of being shy. <keyword id="6072225" type="PERSON" weightage="20" keywordseo="joy-chatterjee">Joy Chatterjee</keyword>, DGM, <keyword id="146847" type="COMPANY" weightage="20" keywordseo="mankind-Pharma">Mankind Pharma</keyword> said, “Through this campaign the intention is to show that we are committed towards our customer’s safety and want to ensure that sex always stays as an act of pleasure, along with safety. We want to communicate to the masses to just "Use A Condom" to avoid AIDS and when it comes to a physical relationship, safety plays an important role in strengthening the bond between partners”. Sex causes a whirlwind of emotions that can take anyone to the universe of happiness, relaxation and contentment. Though sex is the most delightful feeling, it may also open the gates of sexually transmitted diseases (STDs) without posing any warning. BE SAFE!

Manforce Condoms promotes its competitors in its latest ad for World AIDS Day

<ul><li>Mankind Pharma listed at a 20% premium, beating grey market expectations.</li><li>The market capitalisation of the company stands at ₹57,045 crore.</li><li>The grey market had indicated a premium of 10% over the IPO price.</li></ul>After listing at a 20% premium, condom manufacturer Mankind Pharma’s stock ran up 9.5% on Tuesday. In all, its first day’s closing price at ₹1,424, was 32% higher than its issue price. Its issue price was at ₹1,080 per share. Thanks to its stellar debut, Mankind Pharma entered the list of top 100 companies as per market capitalisation, on BSE and NSE. It beat the likes of Canara Bank, UPL, Hero MotoCorp, Zomato to enter the stock exchanges at rank 86, with a marketcap of ₹57,045 crore. The market rally during the day that led to <a href="https://www.businessinsider.in/stock-market/news/mankind-pharma-spicejet-upl-among-stocks-to-watch/articleshow/100076439.cms">Sensex crossing the 62,000 level </a>for the first time since December 2022, also aided the debut. As many as seven companies listed on the exchanges this year, and Mankind Pharma has provided the best listing gains amongst them all. An investor in the IPO would have gained ₹344 per one stock by the end of the day. Beating the grey market The listing gains were above expectations as the grey market indicated a premium of 10% to the IPO price. <a href="https://www.businessinsider.in/stock-market/news/grey-market-premium-what-is-it-and-where-is-it-coming-from/articleshow/95454371.cms">GMP is the premium at which IPO shares are traded</a> in an unofficial market before they are listed on the stock exchanges. The ₹4,326 crore IPO generated good demand from investors, with the issue being subscribed 15.32 times. The qualified institutional buyer portion was subscribed the most at 49.16 times. The portion reserved for retail witnessed weak demand as it was subscribed just 0.92 times, while that of the non-institutional investors was subscribed 3.8 times.The IPO was a complete offer for sale (OFS) of over 4 crore equity shares by the promoters and existing shareholders of the company. The company will not receive any proceeds from the offer. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;" class="redcator-table-advance"><colgroup></colgroup><col /><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">IPOs in 2023 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Issue price </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Listing day gain </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Current market price </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Radiant Cash Management </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹94 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹10.70 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹95.15 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Sah Polymers </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹65 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹24.25 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹76.01 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Divgi TorqTransfer Systems </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹590 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹15.15 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹636.40 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Global Surfaces </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹140 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹30.90 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹214 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Udayshivkumar Infra </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹35 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-₹1.61 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹30 </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Avalon Technologies </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹436 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">-₹38.55 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹355 </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table>Source: BSE The company manufactures a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its wide range of offerings include condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;" class="redcator-table-advance"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Financials of some famous brands owned by company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Domestic sales (Dec 2022) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">% market share </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Manforce (condom) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹461 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">29.6% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Prega News (pregnancy detection kit) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹184 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">79.7% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Unwanted-72 (emergency contraceptives) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹108 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">61.7% </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table> It has 25 manufacturing facilities across Himachal Pradesh, Sikkim, Rajasthan, Andhra Pradesh, Maharashtra and Uttarakhand. The company says that after India, its major markets are the US, Bangladesh, Sri Lanka and Nepal. Any developments in the pharmaceutical industry in these regions could impact on its business operations. The company is also looking to acquire brands and diversify its therapeutic portfolio. “We aim to deepen our presence in our existing markets and facilitate our entry into new markets. We intend to strategically acquire brands and companies across key markets as well as explore in-licensing and co-development opportunities with other companies to diversify our therapeutic portfolio,” the company said in its DRHP. Its products are sold in 20 countries, including the US, Latin America, Southeast Asia, Africa, the Middle East and the Commonwealth of Independent States (CIS). Mankind Pharma’s profitability has grown over 37% in the last three financial years. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;" class="redcator-table-advance"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Year </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Revenue from operations </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Net profit </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY22 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹7,781 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,452 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY21 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹6,214 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,293 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY20 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹5,865 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹ 1,056 crore </td></tr></tbody><tbody></tbody><tbody></tbody><tbody></tbody></table> SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/auto/news/fy23-scorecard-tvs-motor-fares-better-than-bajaj-auto-hero-motocorp-on-profits-and-margins/articleshow/100082560.cms">FY23 Scorecard: TVS Motor fares better than Bajaj Auto, Hero MotoCorp on profits and margins</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/rail-vikas-nigam-marks-a-strong-journey-in-2023-share-price-of-68-to-140/slidelist/100069014.cms">From ₹68 to ₹140, this multibagger stock marks a strong journey in 2023</a>

Mankind Pharma stock runs up in trade after listing at 20% premium

<ul><li>Mankind Pharma is likely to announce its share allotment status on May 3.</li><li>The IPO received great demand from investors as the issue was subscribed 15.32 times.</li><li>The shares will be listed on May 8 on NSE and BSE.</li></ul>Condom manufacturer Mankind Pharma is likely to announce the allotment status of its initial public offering (IPO) on May 3. The ₹4,326 crore IPO received great demand from investors, with the issue being subscribed 15.32 times. The qualified institutional buyer portion was subscribed the most at 49.16 times. The portion reserved for retail witnessed weak demand as it was subscribed just 0.92 times, while that of the non-institutional investors was subscribed 3.8 times. Currently, shares of the condom maker are demanding a premium of ₹80 per share in the grey market. <a href="https://www.businessinsider.in/stock-market/news/grey-market-premium-what-is-it-and-where-is-it-coming-from/articleshow/95454371.cms">GMP is the premium at which IPO shares are traded</a> in the unofficial market before they are listed on the stock exchanges. The company’s shares will be listed on the stock exchanges on May 8. The IPO was a complete offer for sale (OFS) of over 4 crore equity shares by the promoters and existing shareholders of the company. The company will not receive any proceeds from the offer. The company sells Manforce condoms and Prega News pregnancy detection kits. It manufactures a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its wide range of offerings include condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations. Here is how to check <keyword id="17300455" type="General" weightage="20" keywordseo="Mankind-Pharma-IPO-allotment-status" source="Orion">Mankind Pharma IPO allotment status</keyword> on the stock exchange websites: <ul><li>Go to the <a href="https://www.bseindia.com/investors/appli_check.aspx">BSE website</a> or NSE website <a href="https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp">here</a>.</li><li>On BSE, Select 'Equity' and then from the dropdown, select ‘Mankind Pharma’.</li><li>Now, enter your application number and PAN.</li><li>Click on 'Search'.</li><li>Please note the details will only be available once the shares are allotted.</li></ul>You can also visit the registrar website (Kfin Technologies) to check your application status. <ul><li>Visit the registrar's website <a href="https://kprism.kfintech.com/ipostatus/">here</a>.</li><li>Click on 'Select company' and click on ‘Mankind Pharma’.</li><li>Once the company is selected, you will have to enter either your PAN details, the application number, or the client ID.</li><li>Enter the captcha code and click ’submit’. </li></ul>Once you hit 'submit', the status of your application will appear on the screen. Please ensure the details that you provide are correct. It will show the number of shares you subscribed to and the number of shares allotted to you. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/investment/news/silver-may-offer-an-attractive-investment-option-as-china-reopens/articleshow/99944101.cms">Silver on an upswing – The metal may offer an attractive investment option as China reopens</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/corporates/news/adani-total-gas-reports-8-rise-in-fy23-net-profit-to-546-croreannounces-plans-to-expand-ev-charging-points-to-3000/articleshow/99936234.cms">Adani Total Gas reports 8% rise in FY23 net profit to ₹546 crore,announces plans to expand EV charging points to 3,000</a>

Mankind Pharma IPO: Here’s how to check allotment status online

<ul><li>As compared to last year, there has been a 30% increase in the <keyword id="8398768" type="UNKNOWN" weightage="20" keywordseo="sale-of-condoms">sale of condoms</keyword> driven by demand from non-metros. </li><li>The growth driven by lack of access to variety, hesitancy to purchase from the store.</li><li>Popular condom brands on Snapdeal include Durex, Kamasutra, Skore, Kohinoor, and Manforce.</li></ul>Snapdeal has revealed that 56% of condoms on its platforms are bought by the audience sitting in Tier III cities and beyond. As compared to last year, there has been a 30% increase in the sale of condoms driven by demand from non-metros. Eight out of ten orders of condoms were from non-metros. 56% of the demand from non-metros was from Tier III cities like Imphal, Moga, Aizwal, Agartala, Ernakulam, Malapuram, Shillong, Silchar, Udaipur, Hissar, Nagaon, Bardhaman, Dibrugarh, Kanpur, and Ahmednagar. Sexual health wellness and population control is an important focus in India. The growth and demand for condoms on Snapdeal is driven by a lack of access to a huge variety in non-metros. As Snapdeal has a discreet shipping policy for these products, users have also become confident and more open to buying condoms from the platform. “Considering the continuing hesitation around the subject of sex and its education, people are still reluctant to purchase condoms from a store. Online marketplaces have become a go-to place as it provides discreet and hassle-free purchase, which has led to increasing volumes,” says a Snapdeal spokesperson. Popular condom brands on Snapdeal include Durex, Kamasutra, Skore, Kohinoor, and Manforce. This National <keyword id="34644" type="PERSON" weightage="20" keywordseo="World-AIDS-Day">World Aids Day</keyword>, Snapdeal launched special discounts of up to 50 percent on bestselling condoms. The offer runs for the entire week. Snapdeal has put together a range of over 600 different condoms.

Snapdeal reveals 56% of sale of condoms on its platform comes from Tier III cities and beyond

<ul><li>The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the company's promoters and existing shareholders.</li><li>This will be the seventh IPO to be listed on exchanges in 2023 amid an uncertain macro environment.</li><li>The shares of the company are currently commanding a huge <keyword id="938640" type="General" weightage="20" keywordseo="grey-market-premium" source="Orion">grey market premium</keyword>, or GMP, of ₹100 per share.</li><li>Promoters selling shares include co-founders Ramesh Juneja and Rajeev Juneja, CEO Sheetal Arora, Cairnhill CIPEF, Cairnhill CGPE, Beige and Link Investment Trust.</li></ul>Condom manufacturer <keyword id="146847" type="General" weightage="20" keywordseo="Mankind-Pharma" source="Orion">Mankind Pharma</keyword> is all set to open its ₹4,326 crore initial public offering (IPO) on April 25 and close it on April 27. This will be the seventh IPO to be listed on the exchanges in 2023 amid an uncertain macro environment. The price band of the IPO is set at ₹1,026 - ₹1,080 per share. The shares of the company are currently commanding a huge grey market premium, or GMP, of ₹100 per share. <a href="https://www.businessinsider.in/stock-market/news/grey-market-premium-what-is-it-and-where-is-it-coming-from/articleshow/95454371.cms">GMP is the premium at which IPO shares are traded</a> in an unofficial market before they are listed on the stock exchanges. The IPO will comprise an offer for sale (OFS) of over 4 crore equity shares by the promoters and existing shareholders of the company, which sells Manforce condoms and Prega News pregnancy detection kits. The company will thus not receive any proceeds from the offer. Promoters selling shares include co-founders Ramesh Juneja and Rajeev Juneja, chief executive officer Sheetal Arora, Cairnhill CIPEF, Cairnhill CGPE, Beige Limited and Link Investment Trust. The company’s shares will be allotted to investors on May 3 and will be listed on the stock exchanges on May 8. The company manufactures a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its wide range of offerings include condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti-acne preparations. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Financials of some famous brands owned by company </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Domestic sales (Dec 2022) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">% market share </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Manforce (condom) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹461 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">29.6% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Prega News (pregnancy detection kit) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹184 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">79.7% </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Unwanted-72 (emergency contraceptives) </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹108 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">61.7% </td></tr></tbody></table> It has 25 manufacturing facilities across Himachal Pradesh, Sikkim, Rajasthan, Andhra Pradesh, Maharashtra and Uttarakhand. The company says that after India, its major markets are the US, Bangladesh, Sri Lanka and Nepal, and any developments in the pharmaceutical industry in these regions could impact on its business operations. Besides, Mankind Pharma is exposed to government price controls which could negatively affect its results of operations. “In addition to normal price competition, the prices of certain of our products are or may be restricted by price controls imposed by governments and healthcare providers in India, or in other countries to which we export our products, which may limit the revenue we earn from certain of our products,” said the company in red herring prospectus. The company is also looking to acquire brands and diversify its therapeutic portfolio. “We aim to deepen our presence in our existing markets and facilitate our entry into new markets. We intend to strategically acquire brands and companies across key markets as well as explore in-licensing and co-development opportunities with other companies to diversify our therapeutic portfolio,” the company said in its DRHP. Its products are sold in 20 countries, including the US, Latin America, Southeast Asia, Africa, the Middle East and the Commonwealth of Independent States (CIS). Mankind Pharma’s profitability has grown over 37% in the last three financial years. <table style="border-width: initial; border-style: none; table-layout: fixed; width: 468pt;"><colgroup></colgroup><col /><col /><col /><tbody><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Year </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Revenue from operations </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">Net profit </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY22 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹7,781 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,452 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY21 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹6,214 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹1,293 crore </td></tr><tr><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">FY20 </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹5,865 crore </td><td style="border-left:solid #000000 1pt;border-right:solid #000000 1pt;border-bottom:solid #000000 1pt;border-top:solid #000000 1pt;vertical-align:top;padding:5pt 5pt 5pt 5pt;overflow:hidden;overflow-wrap:break-word;">₹ 1,056 crore </td></tr></tbody></table> SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/startups/news/zomatos-cost-control-efforts-are-hurting-the-startup-strike-at-blinkit-to-hurt-revenues-by-1/articleshow/99609906.cms">Zomato's cost control efforts are hurting the startup: Strike at Blinkit to hurt revenues by 1%</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/stock-market/news/demat-account-additions-slow-as-markets-languish-upstox-icici-securities-5paisa-capital-lose-market-share/articleshow/99607157.cms">Demat account additions slow as markets languish; Upstox, ICICI Securities, 5Paisa Capital lose market share</a>

Condom maker Mankind Pharma’s ₹4,326 crore IPO to open next week on April 25

<ul><li>Reckitt’s Durex has launched its first-ever product innovation for the Indian market, thin flavored condoms.</li><li>It got around 12 influencers to spark conversations on social media about bedroom distancing to create interest around the launch of its new product and advertisement.</li><li>The brand is trying to expand its reach in Tier II and III markets with its latest innovation.</li><li>Dilen Gandhi, Regional Marketing Director, South Asia – Health &amp; Nutrition, Reckitt talks to us about the campaign, larger marketing strategy that has helped Durex become one of the category leaders in less than six years, focus areas for H2 2021, and larger vision for the brand.</li></ul>When Reckitt’s Durex launches a new product in the market, it is hard to miss it because there’s a massive conversation on the social media universe involving multiple A-list influencers and celebrities. The brand knows how to build curiosity and hold consumers’ attention till the very end. Durex usually starts its campaign by giving its consumers a little sneak peek with a poster. To build on this buzz further, the brand shares some intriguing data points which encourage consumers to talk about their own stories. It is followed by a teaser, influencer collaboration, and finally the big reveal - the product advertisement. In the past, Durex had used a similar strategy for its product Durex Mutual Climax Condoms and Invisible Condoms. For the former, it started by telling people on social media that nearly 70% of women in India don’t orgasm every time they have sex. It eventually announced the launch of its product with a campaign. It spoke on the issue of orgasm inequality by normalising conservations and providing product solutions for both men and women so that they #ComeTogether, thereby helping reduce the orgasm gap. For the second product launch, Durex’s Invisible Condoms, it used a counter-intuitive approach and asked consumers to forget condoms. The idea was to create interest around its thinnest condoms. For the launch of Thin Flavoured Condoms that come in Chocolate, Strawberry and Bubble gum, Durex followed a similar route. It divided its campaign into three legs: get people talking on social media about #EndBedroomDistancing, launch the TV spot that employs a metaphor to demonstrate how Durex Extra Thin Flavoured condoms can help end it and the third act of the campaign continues the conversation with memes and influencer posts. The campaign is conceptualised by <keyword id="7001513" type="General" weightage="20" keywordseo="havas-group-india" source="Orion">Havas Group India</keyword>. The first leg of the campaign saw participation from celebrities and influencers like Harshvardhan Rane, Badshah, Abhijeet, Prateek Babar, with posts on their profiles wondering what’s bedroom distancing. Two days later, Durex announced India’s thinnest condoms. The same influencers also posted a second set of videos on their respective profiles, revealing what the buzz was all about, and then came the final commercial unveiling the product. <div type="Youtube" id="10fRuRwzAMg" title="Durex Extra Thin Flavoured Condoms | #FeelTheFlavour" thumbUrl="https://i.ytimg.com/vi/10fRuRwzAMg/mqdefault.jpg"></div> According to Durex’s consumer survey, over 60% of condom sales in India are in the flavoured condoms category. However, it identified a gap: the focus in the category has primarily been on flavours and not on product innovation addressing intimacy issues faced by the consumers in this segment. And that’s how the idea of launching thin flavoured condoms was born. This is Durex’s first product which is primarily made for India. Sharing the insight behind the campaign, Dilen Gandhi, Regional Marketing Director, South Asia – Health &amp; Nutrition, Reckitt said, “The objective of the campaign was to get everyone talking about it. This is the first time we have created an innovation specifically for the Indian market. To make people aware of this innovation, we decided to take the ‘classic Durex route’ -- create a campaign that could actually lead to a lot of conversation. The difference between Durex’s advertising and many other brands is that we put consumers at the heart of our marketing. Our campaigns always have something intriguing, which pulls the consumer in and this time, this whole notion was bedroom distancing. We take something that is topical, this time, unfortunately, it is the notion of social distancing and combine it with something unexpected, which is what leads to conversation. Reduction of distancing here is in with the promise of the product to bring both partners, physically and emotionally, closer.” Durex partnered with 12 influencers and celebrities to create buzz around its launch. It followed a simple filtering system: how popular is the influencer among its target audience, how well does their market image fit with Durex and how credibly will the influencer convey the message. It is due to the brand’s partnership with influencers that there’s a lot of chatter on social media around its campaign and Gandhi is hoping that this would translate into ROI and sales on the ground. <cmsannotation type="cmsannotation" annotationid="Becoming the second largest player in 6 years" text="Becoming the second largest player in 6 years">Becoming the second largest player in 6 years</cmsannotation> Condoms are still a hush-hush concept in India and condom marketing is an equally tricky business. So it is important for condom brands to create conversations that are risque and yet tasteful, and Durex has mastered it over the years. It is because of its strong marketing strategy that the brand has grown from strength to strength. Six years ago, when Reckitt launched Durex, it was competing against Manforce with a 32.4% market share, followed by Moods, Skore, Kamasutra and Kohinoor. In 2017, it onboarded Ranveer Singh to cater to India’s youth. In 2019 came its revolutionary campaign, Orgasm Equality and Durex started working on building an inclusive conversation in the category. With its Bees and the Birds campaign in 2020, Durex upped its marketing strategy by catering to adolescents through art and literature. When most brands in the category objectified women, Durex spent huge marketing dollars changing the narrative, targeting them and establishing itself as a brand that cares about making a difference. Its active moment marketing has also helped Durex stay on top of the mind. According to Neilsen, the condom category is dominated by Manforce with a 32.4% share in value, followed by Durex at 13.8%. So we asked Gandhi about what worked for the brand, it's larger marketing strategy and success mantra. He said, “The most important metric for us is, obviously, business results. We are very focused on ensuring that every marketing dollar that we spend gives us a return in terms of business results. The leading indicator for us is driving conversations, sentiment, reach, and frequency. Ultimately, we are looking at equity.” “Our marketing objective has always been to normalise talking about sex in India. Now, the challenge for us is how do we keep getting better,” added Gandhi. For the rest of 2021, Durex would be focusing on making its Thinnest Flavoured condoms more available in our country and working on campaigns that redefine pleasure “It is more than just a market share game for us. It is about shaping the category, we try to offer the unexpected to our consumers. While we are focused on business results, we believe results will come not just from market share but by redefining the category which is far more equal, inclusive and pleasurable. We want condoms to be something which is normal for everyone, something that is used for pleasure and not just for protection. Apart from that, making sure that our Thinnest flavoured condoms are available more and more is definitely a big focus area. The smaller towns are going to be a big focus area too. This innovation was created for the non-metros,” shared Gandhi.

How Durex cleverly uses influencer marketing to trigger conversation around its new product launches

<ul><li>Manforce's new campaign, #YouAreNotAlone gives a different spin to typical <keyword id="41008" type="ENTERTAINMENT" weightage="20" keywordseo="Valentines-Day">Valentine's Day</keyword> communications.</li><li>It has asked couples to stay careful in public places.</li><li>The aim of the campaign, conceptualized by <keyword id="4969050" type="PERSON" weightage="20" keywordseo="ADK-Fortune">ADK-Fortune</keyword>, is to bring to light the perils of indulging in PDA thinking one is alone in public spaces with complete disregard to prying eyes who are always on the lookout for vulnerable couples.</li></ul>As we come closer to Valentine's Day, when most brands urge people to shower love on their loved ones, condom brand Manforce has come out with a very different communication. People have different opinions about what is the limit of Public Display of Affection (PDA). With time, we have at least matured enough to not feel uncomfortable with a simple hug, holding of hands or a goodbye kiss at public places. The problem starts only when we cross the line. And it is not so much about disregarding other’s feelings but rather it’s putting oneself in danger thinking you are alone. What they forget is there is nothing private about the public place. The new campaign by the brand brings to light the perils of indulging in PDA thinking you are alone with complete disregard to prying eyes who are always on the lookout for such vulnerable couples. 
 <div type="Youtube" id="uUCDF3WEOJk" title="Manforce Condoms | Valentine's Day | #YouAreNotAlone" thumbUrl="https://i.ytimg.com/vi/uUCDF3WEOJk/mqdefault.jpg"></div>



 Commenting on the campaign, <keyword id="6072225" type="PERSON" weightage="20" keywordseo="joy-chatterjee">Joy Chatterjee</keyword>, DGM, <keyword id="146847" type="COMPANY" weightage="20" keywordseo="mankind-Pharma">Mankind Pharma</keyword> said, “As a responsible brand, we take pride in sensitizing couples about safe sex. This time we have a strong message to those couples who indulge in PDA thinking they are doing it within the four walls of their house. It’s important for them to understand where they are, what they are doing and how their action can ruin their life.” The #YouAreNotAlone campaign has been conceptualized and executed by ADK Fortune Communications Pvt. Ltd., Gurgaon. “After our successful campaign #ShutThePhoneUp, we wanted to continue with this momentum of sensitizing people about ‘safe sex’. And that is how we arrived at our fresh campaign #YouAreNotAlone. The campaign speaks about the danger of letting your guard down in a public place. Irrespective of what the place may look like, there is always danger lurking around and that can ruin your life”, says <keyword id="4236018" type="PERSON" weightage="20" keywordseo="Subroto-Pradhan">Subroto Pradhan</keyword>, Managing Partner, ADK-Fortune.

This Valentine's Day, Manforce has a word of caution for couples

<img class="gwt-Image" src="/photo/53189611.cms" style="width: 800px; height: 600px;" /> 
<a href="http://www.businessinsider.in/searchresult.cms?query=sunny+leone&amp;sortorder=effectivedate">Sunny Leone</a>, the <a href="http://www.businessinsider.in/searchresult.cms?query=pornstar&amp;sortorder=effectivedate">adult-film star</a>, who has already made a foray into <keyword id="143" type="CITY" weightage="100" keywordseo="Bollywood">Bollywood</keyword>, is often talked about for her boldness, outspokenness and her interesting endorsements- the chief being the <a href="http://www.businessinsider.in/searchresult.cms?query=condom+brand&amp;sortorder=effectivedate">condom brand</a> <keyword id="1093769" type="UNKNOWN" weightage="100" keywordseo="Manforce">Manforce</keyword>. 
 
Sunny is probably the only popular face in the history of <a href="http://www.businessinsider.in/searchresult.cms?query=bollywood&amp;sortorder=effectivedate">Bollywood</a> to have proudly endorsed a condom brand. Commenting on the fact that A-list actresses don’t choose to endorse <keyword id="27993" type="UNKNOWN" weightage="100" keywordseo="condoms">condoms</keyword>, she said that that depends on ‘a person’s comfort levels and their life goals.’ 
 
Talking about why she chose to be a face for a <a href="http://www.businessinsider.in/searchresult.cms?query=condoms&amp;sortorder=effectivedate">condom </a>brand, Sunny said, “I believe in <a href="http://www.businessinsider.in/searchresult.cms?query=safe+sex&amp;sortorder=effectivedate">safe sex</a>. It has always been a part of my belief system and that is why I chose to associate myself with a brand like this.” 
 At the calendar launch of the condom brand, <keyword id="836886" type="PERSON" weightage="100" keywordseo="Sunny-Leone">Sunny Leone</keyword> also urged her fans to use condoms to avoid unwanted pregnancy and remain protected from various sexually transmitted diseases. 
 
“I think safe <a href="http://www.businessinsider.in/searchresult.cms?query=sex&amp;sortorder=effectivedate">sex</a> and condoms should actually get married. It’s something that goes hand in hand, especially for younger generation,” explained the Leela actress. 
 
She further went on to reveal that people in the US are also as shy and secretive while buying condoms as people in India are.

Here's what Sunny Leone has to say about sex

<ul><li>Income tax department is conducting searches at Mankind Pharma’s premises in Delhi, checking documents, and questioning people.</li><li>Mankind Pharma has been in the news since its <a href="https://www.businessinsider.in/stock-market/news/condom-maker-mankind-pharma-lists-at-20-premium-beats-grey-market-expectations/articleshow/100090002.cms">stellar debut on Tuesday </a>with 20% listing gains.</li><li>The company is known for products like MANforce condoms, Prega News pregnancy detection kits and Gas-o-Fast sachets.</li></ul>The Income Tax department on Thursday conducted searches on the premises of Mankind Pharma over allegations of tax evasion, official sources said. A PTI report said that searches are being conducted on the company premises in Delhi and nearby locations, documents are being checked and people are being questioned as part of the action launched early this morning. E-mail and queries sent by PTI to the company remained unanswered. Mankind Pharma recently went public, to raise ₹4,326 crore. The initial public offer was a complete offer for sale and its promoters received the proceeds from the share sale. Added to that, its <a href="https://www.businessinsider.in/stock-market/news/condom-maker-mankind-pharma-lists-at-20-premium-beats-grey-market-expectations/articleshow/100090002.cms">stock listed at a 22% premium</a> on May 9, and the company’s marketcap stands at ₹56,108 crore as of Thursday. The pharma company also entered the <a href="https://www.businessinsider.in/business/corporates/news/mankind-pharma-debuts-in-top-100-as-per-market-value-after-a-stellar-listing/articleshow/100123765.cms">top 100 companies club </a>on its debut day. On Thursday, it ranks at 90 in terms of largest listed companies in India, leaving behind the likes of Punjab National Bank, Hero MotoCorp, UPL, Indian Hotels and Zomato. Analysts say that the stock may continue to do well going ahead, backed by strong fundamentals. “Given its healthy financial track record, domestic focus and extensive network, Mankind is likely to continue doing well,” Hemang Jani, Head of Equity Strategy, Motilal Oswal Financial Services. “Moreover the healthcare sector was a laggard over the last one year but started seeing traction over the last two months as the monthly pharma data showed improvement,” added Jani. Macquarie Research has initiated coverage on the company with an ‘Outperform’ rating and a target price of ₹1,400. The brokerage believes that Mankind Pharma is at a discounted valuation than its peers — Abbott India, GSK India and Pfizer India. “We believe the company’s net profit could double (&gt;2x) in the next three years, driven by: a) continued sales outperformance relative to Indian pharma market (IPM), b) mix shift towards chronic therapies, and c) unlocking of meaningful operating leverage as salesforce productivity improves,” said the brokerage firm. The company’s stock has been falling after the listing day amid volatile market conditions. Today, the stock is down nearly 2% at 1,356. Incorporated in 1991, Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. Its product portfolio includes MANforce condoms, Prega News pregnancy detection kits and Gas-o-Fast sachets. The company said that it’s looking to acquire brands and diversify its therapeutic portfolio to facilitate entry into new markets. (With inputs from PTI) SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/corporates/news/lt-q4-net-profit-rises-10-to-3987-crore-cautiously-optimistic-about-fy24/articleshow/100137513.cms">L&amp;T Q4 net profit rises 10% to ₹3,987 crore, cautiously optimistic about FY24</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/entertainment/news/ipl-2023-scores-over-1300-crore-video-views-on-jiocinema-in-the-first-five-weeks/articleshow/100155165.cms">IPL 2023 scores over 1,300 crore video views on JioCinema in the first five weeks</a>

Income Tax department raids freshly listed Mankind Pharma’s premises over alleged tax evasion

<ul><li><keyword id="146847" type="General" weightage="20" keywordseo="mankind-pharma" source="Orion">Mankind Pharma</keyword> entered the top 100 companies club in terms of highest market capitalization on listing day.</li><li>Analysts say that the dazzling listing gains by Mankind Pharma has brought back life into the primary market.</li><li>Macquarie Research has initiated coverage on the company with an ‘Outperform’ rating and a target price of ₹1,400.</li></ul>After a lull period of over four months in 2023, the stellar debut of Mankind Pharma has rekindled optimism in the primary market. With a 32% run up in stock price as compared to the issue price, the company provided investors with good profits. With a marketcap of ₹56,108 crore, it also entered the top 100 companies club on its debut day. It ranks at 84 in terms of largest listed companies in India, leaving behind the likes of Punjab National Bank, Hero MotoCorp, UPL, Indian Hotels and Zomato. Retail investors’ bonanza All the retail investors who had invested in the IPO have been allotted the shares, helping them gain from the stock run up. Only 92% of the portion of shares reserved for retail investors were subscribed, hence every investor who applied were allotted stocks. Overall, the ₹4,326 crore IPO generated good demand from investors, with the issue being subscribed 15.32 times, thanks to the qualified institutional buyers who subscribed the most at 49.16 times. Analysts say that the dazzling listing gains by Mankind Pharma has brought back life into the primary market. “Fast growing India-centric Mankind Pharma truly deserves credit for bringing back life into the primary market during CY 2023 with a stellar listing which provided a 30% return to retail investors. The icing on the cake was the allotment itself wherein almost all retail investors were allotted the shares,” said S Ranganathan, head of research at LKP Securities. On Wednesday, shares of the company were down 2.2% to 1,390 per share, as the <a href="https://www.businessinsider.in/stock-market/news/lt-nazara-tech-adani-group-among-stocks-in-focus/articleshow/100118610.cms">Indian stock markets remained volatile</a>, ahead of US inflation data to be released later today. Fundamentals are strong, say analysts Analysts say that the stock may continue to do well backed by its strong fundamentals. “Mankind Pharma got listed at 20% premium to the IPO price, thus receiving a strong response. The primary market saw an IPO hitting after a long gap, thus the interest was high. Moreover the healthcare sector was a laggard over the last one year but started seeing traction over the last two months as the monthly pharma data showed improvement. Given its healthy financial track record, domestic focus and extensive network, Mankind is likely to continue doing well,” Hemang Jani, Head of Equity Strategy, Motilal Oswal Financial Services. Macquarie Research has initiated coverage on the company with an ‘Outperform’ rating and a target price of ₹1,400. “We believe the company’s net profit could double (&gt;2x) in the next three years, driven by: a) continued sales outperformance relative to Indian pharma market (IPM), b) mix shift towards chronic therapies, and c) unlocking of meaningful operating leverage as salesforce productivity improves,” said the brokerage firm. The brokerage believes that Mankind Pharma is at a discounted valuation than its peers — Abbott India, GSK India and Pfizer India. Mankind Pharma has 50 brands under it, which are cheaper than its peers in respective categories, and 39 brands out of them have outperformed their respective category growth. These include products like Mankind Unwanted Kit, Prega News, Gas-O-Fast and so on. The company entered into the consumer healthcare business in 2007 and has established brands in condoms, pregnancy detection, emergency contraceptives, antacid, vitamin and mineral supplement and anti-acne preparations categories. Some of its key brands such as Manforce, Prega News and Unwanted-72 are market leaders in their respective categories. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/business/news/mutual-fund-company-stocks-bleed-this-year-thanks-to-tax-hit-on-debt-funds-and-strict-expense-ratio-norms/articleshow/100110663.cms">Mutual fund company stocks bleed this year, thanks to tax hit on debt funds and strict expense ratio norms</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/finance/banks/news/india-china-amongst-top-gold-buyers-in-march-quarter-as-central-banks-hoard-yellow-metal/slidelist/100103402.cms">India, China amongst top gold buyers in March quarter as central banks hoard yellow metal</a>

Mankind Pharma enters top 100 companies by market cap after a stellar listing

<ul><li>The former captain of team India got his first endorsement deal in 2005 with Mysore Sandal Soap. </li><li>MS Dhoni added 3% share of ad volume on TV with an average visibility of 5 hours per day across all TV channels in the last six months.</li></ul>One of India’s biggest sporting icons in recent times, <keyword id="10138" type="PERSON" weightage="20" keywordseo="Mahendra-Singh-Dhoni">Mahendra Singh Dhoni</keyword>, retired on August 15. As a brand endorser, he was one of the most visible faces on television with more than 13 brands in his kitty. However, his retirement from international cricket has not changed anything. After Dhoni took to Instagram to announce his retirement, brands across categories from the likes of Amul to Manforce condom reminded the audience why he will always be a good fit for brands. <div type="twitter" handle="Amul_Coop" handlename="Amul.coop" image="http://pbs.twimg.com/profile_images/651028295425765376/1qJVp6Eu_normal.jpg" favoritecount="10861" retweetcount="2884" status="We wish all the best to M S Dhoni @msdhoni for the next innings in his life! https://t.co/UvgGHYGPI5" createdat="1597510835000" id="1294680399621185537"></div> <div type="twitter" handle="ManforceIndia" handlename="Manforce Condoms" image="http://pbs.twimg.com/profile_images/982657058876125186/v4fkHTaZ_normal.jpg" favoritecount="72" retweetcount="24" status="&quot;Mahi maar raha hai!&quot; Guess we won't hear this anymore! 😞 #DhoniRetires https://t.co/FEWz6hwgrL" createdat="1597516888000" id="1294705787059597312"></div> For millennials, he will always be a star from a small town like Ranchi who made it big in the industry. He stood for leadership, determination, empathy, power and yet, had a boy-next-door image. <div type="twitter" handle="anandmahindra" handlename="anand mahindra" image="http://pbs.twimg.com/profile_images/1284398843853864966/qVI16-Sn_normal.jpg" favoritecount="5462" retweetcount="308" status="Much has been said about what #Dhoni brought to the game. I’m no expert on cricket &amp; I remember I 1st noticed him… https://t.co/WmENpCWkSe" createdat="1597645758000" id="1295246306797957120"></div> According to a TAM report that provides a ranking of top 10 celebrities in brand endorsements space in the period of Jan-Jun’20, MS Dhoni added 3% share of ad volume on TV with an average visibility of 5 hours per day across all TV channels. <img src="https://lh6.googleusercontent.com/yV7-uPQxrB942c7d2LGUE208LNdOGHFH1cZquLTCgrAstSQuuYE2XRad4nEgURRgtR1SEDuLK_YREi0oaK1bPX6qMulHAv1fw28poZNFPdbKvuVnq9ADqcQRvOJASNEt0oapLsoC" /> According to a Duff &amp; Phelps Celebrity Brand Valuation study conducted in 2019, the former captain of team India stood at ninth spot for brand rankings and was valued at $41.2 million. In his early days, Dhoni was known for his cool hairstyle and suddenly every guy in the town wanted to follow his mane. It was this cool hairstyle and undeniable charisma that got him his first endorsement deal with Mysore Sandal Soap in 2005. <img src="https://lh3.googleusercontent.com/cO9DpF0FiU6rPsyH5mH5FNzV-2Z9hS7itM50C-sKJJClEMPar8Opwb762zVdEqrNftdOnBYHa8E7qRmzqde7GzZ69ijGC7JAZdX2y6LPe2qQB0ZOzdzvOTQ6bf1ZGEqotCgtRODg" /> Brylcreem hair cream was also quick to recognise this opportunity and approached MS Dhoni for an advertisement. <div type="Youtube" id="s4CXzIrXyx4" title="Brylcream" thumbUrl="https://i.ytimg.com/vi/s4CXzIrXyx4/mqdefault.jpg"></div> While the cricketer may not appear in stadiums from now on, we have got you covered with a list of well-known advertisements featuring Captain Cool! <div type="Youtube" id="v_a-qky1j5g" title="Videocon Shahrukh Dhoni 'Brothers' Commercial" thumbUrl="https://i.ytimg.com/vi/v_a-qky1j5g/mqdefault.jpg"></div> <div type="Youtube" id="cKHLOSSeEHA" title="McDowell's No1 Soda 'Dhoni ki No1 Yaari' by DDB Mudra South &amp; East" thumbUrl="https://i.ytimg.com/vi/cKHLOSSeEHA/mqdefault.jpg"></div> <div type="Youtube" id="FxE3o8crEes" title="Nayi Soch | Son Of Devki" thumbUrl="https://i.ytimg.com/vi/FxE3o8crEes/mqdefault.jpg"></div> <div type="Youtube" id="IuAn-3x3W80" title="M.S.Dhoni latest add Snickers" thumbUrl="https://i.ytimg.com/vi/IuAn-3x3W80/mqdefault.jpg"></div> <div type="Youtube" id="mMjOHAriaQg" title="#SachMein Hardik Pandya, Mahendra Singh Dhoni? #StarValuePack" thumbUrl="https://i.ytimg.com/vi/mMjOHAriaQg/mqdefault.jpg"></div> <div type="Youtube" id="2n3NFAiGd00" title="VIVO IPL: Return of the Super King!" thumbUrl="https://i.ytimg.com/vi/2n3NFAiGd00/mqdefault.jpg"></div> <div type="Youtube" id="kMphceeM15w" title="Lay's Dhoni Elevator ad." thumbUrl="https://i.ytimg.com/vi/kMphceeM15w/mqdefault.jpg"></div> <div type="Youtube" id="VGDP7zrWJdQ" title="MS Dhoni Pepsi Ad" thumbUrl="https://i.ytimg.com/vi/VGDP7zrWJdQ/mqdefault.jpg"></div> <div type="Youtube" id="4_VBJFpYtAw" title="Mastercard Team Cashless India - Independence day film (90sec)" thumbUrl="https://i.ytimg.com/vi/4_VBJFpYtAw/mqdefault.jpg"></div>

You Searched For "Manforce Condoms" and got 13 results

Condom maker Mankind Pharma files papers for an IPO

Bhakti Makwana

Manforce Condoms aims to capture 50% market share by 2023

Karuna Sharma

Manforce Condoms promotes its competitors in its latest ad for World AIDS Day

BI India Partner

Mankind Pharma stock runs up in trade after listing at 20% premium

Bhakti Makwana

Mankind Pharma IPO: Here’s how to check allotment status online

Bhakti Makwana

Snapdeal reveals 56% of sale of condoms on its platform comes from Tier III cities and beyond

BI India Partner

Condom maker Mankind Pharma’s ₹4,326 crore IPO to open next week on April 25

Bhakti Makwana

How Durex cleverly uses influencer marketing to trigger conversation around its new product launches

Karuna Sharma

This Valentine's Day, Manforce has a word of caution for couples

BI India Partner

Here's what Sunny Leone has to say about sex

Poulomi Das

Income Tax department raids freshly listed Mankind Pharma’s premises over alleged tax evasion

Bhakti Makwana

Mankind Pharma enters top 100 companies by market cap after a stellar listing

Bhakti Makwana

A look at Captain Cool Mahendra Singh Dhoni's brand associations

Karuna Sharma